Ditchcarbon
  • Contact
  1. Organizations
  2. Bavarian Nordic
Public Profile
Pharmaceutical Preparation Manufacturing
DK
updated a month ago

Bavarian Nordic Sustainability Profile

Company website

Bavarian Nordic A/S, a leading biotechnology company headquartered in Denmark (DK), is renowned for its innovative approach in the field of immunotherapy and vaccine development. Founded in 1994, the company has made significant strides in combating infectious diseases and cancer, with a strong operational presence across Europe and North America. Specialising in the development of live virus vaccines and immunotherapies, Bavarian Nordic's core products include the smallpox vaccine, IMVAMUNE®, and the cancer immunotherapy candidate, BN-Brachyury. These offerings are distinguished by their unique mechanisms and robust safety profiles, positioning the company as a key player in the biopharmaceutical industry. With a commitment to advancing public health, Bavarian Nordic has achieved notable milestones, including partnerships with global health organisations, solidifying its reputation as a trusted innovator in vaccine technology.

DitchCarbon Score

How does Bavarian Nordic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

44

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Bavarian Nordic's score of 44 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

63%

Let us know if this data was useful to you

Bavarian Nordic's reported carbon emissions

In 2023, Bavarian Nordic reported total carbon emissions of approximately 10,682,000 kg CO2e, comprising 4,364,000 kg CO2e from Scope 1 and 6,318,000 kg CO2e from Scope 2 emissions. This marked a significant increase from 2022, where total emissions were about 2,753,000 kg CO2e. The company has committed to achieving Net Zero emissions by 2050, in alignment with the Paris Agreement, and is currently focused on defining its carbon footprint reduction pathway through 2024. Bavarian Nordic's emissions data is self-reported and does not include Scope 3 emissions. The company has set near-term targets to reduce its carbon footprint, with a commitment to define its reduction pathway in 2024. The company operates within the pharmaceuticals, biotechnology, and life sciences sector and is headquartered in Denmark (DK). Overall, Bavarian Nordic is taking steps towards sustainability, with a clear commitment to reducing its carbon emissions in the coming years.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2017201820192020202120222023
Scope 1
992,000
000,000
000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
1,686,000
0,000,000
0,000,000
0,000,000
0,000,000
000,000
0,000,000
Scope 3
-
-
-
-
-
-
-

How Carbon Intensive is Bavarian Nordic's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Bavarian Nordic's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Bavarian Nordic's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Bavarian Nordic is in DK, which has a very low grid carbon intensity relative to other regions.

Bavarian Nordic's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Bavarian Nordic has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Bavarian Nordic's Emissions with Industry Peers

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 11 hours ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Frequently Asked Questions

Common questions about Bavarian Nordic's sustainability data and climate commitments

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy